Aerpio Pharmaceuticals, Inc. (ARPO)
Price:
2.20 USD
( - -0.02 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
BioNTech SE
VALUE SCORE:
6
2nd position
ADMA Biologics, Inc.
VALUE SCORE:
11
The best
Aurinia Pharmaceuticals Inc.
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The company is headquartered in Blue Ash, Ohio and currently employs 27 full-time employees. The firm is focused on developing treatments for ocular disease. Its lead product candidate is AKB-9778. Its other two pipeline programs include AKB-4924 and ARP-1536. AKB-9778 is a small molecule activator of the Tie-2 pathway, which is being developed for the treatment of diabetic retinopathy (DR). AKB-4924 is a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1alpha), which is being developed for the treatment of inflammatory bowel disease (IBD). ARP-1536 is a humanized monoclonal antibody directed at the same target as AKB-9778. ARP-1536 binds the extracellular domain of vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibiting its ability to interact with Tie-2. As of April 14, 2017, the Company had completed a Phase II trial of AKB-9778 in 144 patients with diabetic macular edema. As of April 14, 2017, the Company had completed Phase Ia clinical trial in healthy volunteers for AKB-4924.
NEWS
The 6 Best Penny Stocks to Buy for September
investorplace.com
2021-08-30 11:24:42Investing in penny stocks can be an intriguing numbers game. With many stocks to choose from, a handful are bound to be winners.
Top Penny Stocks to Buy? Here's 3 That Investors Are Watching
pennystocks.com
2021-08-18 09:02:24Why investors are watching these penny stocks right now The post Top Penny Stocks to Buy? Here's 3 That Investors Are Watching appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy Right Now? 5 To Watch Before September
pennystocks.com
2021-08-13 13:54:35Looking for penny stocks to buy now? The post Best Penny Stocks To Buy Right Now?
Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update
globenewswire.com
2021-08-11 16:10:00CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company, today reported financial results for the three and six months ended June 30, 2021 and provided a business update.
Penny Stocks to Buy Right Now? 4 For Your Late July Watchlist
pennystocks.com
2021-07-18 17:25:00Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?
Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021
pennystocks.com
2021-07-17 12:45:00Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
pennystocks.com
2021-07-12 16:58:42Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm
prnewswire.com
2021-07-10 13:59:00NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction.
Why Aerpio Shares Are Skyrocketing Today
benzinga.com
2021-07-08 13:43:01Shares of microcap biopharma Aerpio Pharmaceuticals, Inc. (ARPO) are advancing strongly Thursday on above-average volume. The upside in reaction a positive analyst action.
DBGI Stock: 13 Things to Know About Digital Brands as Shares Take Off Today
investorplace.com
2021-07-08 12:15:42Digital Brands (DBGI) stock is rocketing higher on Thursday after revealing estimated financial data for its upcoming quarter. The post DBGI Stock: 13 Things to Know About Digital Brands as Shares Take Off Today appeared first on InvestorPlace.
ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring
investorplace.com
2021-07-08 11:36:00Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company's shares a boost today. The post ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring appeared first on InvestorPlace.
Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist
pennystocks.com
2021-07-08 09:03:27Why investors are watching these 7 penny stocks right now The post Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Aerpio Pharmaceuticals Stock Increases Over 45% Pre-Market: Why It Happened
pulse2.com
2021-07-08 07:47:58The stock price of Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) increased by over 45% pre-market. This is why it happened.
Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting
globenewswire.com
2021-06-04 09:15:00CINCINNATI, June 04, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience, Inc. (“Aadi”), a privately-held biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today issued a press release disclosing that a poster has been presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. As previously disclosed, on May 16, 2021, Aerpio entered into an Agreement and Plan of Merger among Aerpio, Aadi, and Aspen Merger Subsidiary, Inc.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aerpio Pharmaceuticals, Inc. - ARPO
prnewswire.com
2021-05-21 21:00:00NEW YORK, May 21, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Aerpio Pharmaceuticals, Inc. ("ARPO" or the "Company") (ARPO) relating to its proposed merger with Aadi Bioscience, Inc. Under the terms of the agreement, ARPO shareholders are expected to own 14.7% of the combined company after the closing of the concurrent PIPE financing transaction. The investigation focuses on whether Aerpio Pharmaceuticals, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.
AERPIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerpio Pharmaceuticals, Inc. - ARPO
businesswire.com
2021-05-20 21:43:00NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Aerpio Pharmaceuticals, Inc. (“the Company”) (NasdaqGS: ARPO) with Aadi Bioscience, Inc. pursuant to which Aerpio shareholders will own approximately 14.7% of the combined company following the closing of the concurrent PIPE financing. KSF is seeking to determine whether the merger and the process that led t
No data to display
The 6 Best Penny Stocks to Buy for September
investorplace.com
2021-08-30 11:24:42Investing in penny stocks can be an intriguing numbers game. With many stocks to choose from, a handful are bound to be winners.
Top Penny Stocks to Buy? Here's 3 That Investors Are Watching
pennystocks.com
2021-08-18 09:02:24Why investors are watching these penny stocks right now The post Top Penny Stocks to Buy? Here's 3 That Investors Are Watching appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy Right Now? 5 To Watch Before September
pennystocks.com
2021-08-13 13:54:35Looking for penny stocks to buy now? The post Best Penny Stocks To Buy Right Now?
Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update
globenewswire.com
2021-08-11 16:10:00CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company, today reported financial results for the three and six months ended June 30, 2021 and provided a business update.
Penny Stocks to Buy Right Now? 4 For Your Late July Watchlist
pennystocks.com
2021-07-18 17:25:00Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?
Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021
pennystocks.com
2021-07-17 12:45:00Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
pennystocks.com
2021-07-12 16:58:42Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm
prnewswire.com
2021-07-10 13:59:00NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction.
Why Aerpio Shares Are Skyrocketing Today
benzinga.com
2021-07-08 13:43:01Shares of microcap biopharma Aerpio Pharmaceuticals, Inc. (ARPO) are advancing strongly Thursday on above-average volume. The upside in reaction a positive analyst action.
DBGI Stock: 13 Things to Know About Digital Brands as Shares Take Off Today
investorplace.com
2021-07-08 12:15:42Digital Brands (DBGI) stock is rocketing higher on Thursday after revealing estimated financial data for its upcoming quarter. The post DBGI Stock: 13 Things to Know About Digital Brands as Shares Take Off Today appeared first on InvestorPlace.
ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring
investorplace.com
2021-07-08 11:36:00Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company's shares a boost today. The post ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upgrade Sends Shares Soaring appeared first on InvestorPlace.
Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist
pennystocks.com
2021-07-08 09:03:27Why investors are watching these 7 penny stocks right now The post Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Aerpio Pharmaceuticals Stock Increases Over 45% Pre-Market: Why It Happened
pulse2.com
2021-07-08 07:47:58The stock price of Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) increased by over 45% pre-market. This is why it happened.
Aerpio Provides Second Update on Aadi Bioscience Presentation at the ASCO 2021 Virtual Meeting
globenewswire.com
2021-06-04 09:15:00CINCINNATI, June 04, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience, Inc. (“Aadi”), a privately-held biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today issued a press release disclosing that a poster has been presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. As previously disclosed, on May 16, 2021, Aerpio entered into an Agreement and Plan of Merger among Aerpio, Aadi, and Aspen Merger Subsidiary, Inc.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aerpio Pharmaceuticals, Inc. - ARPO
prnewswire.com
2021-05-21 21:00:00NEW YORK, May 21, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Aerpio Pharmaceuticals, Inc. ("ARPO" or the "Company") (ARPO) relating to its proposed merger with Aadi Bioscience, Inc. Under the terms of the agreement, ARPO shareholders are expected to own 14.7% of the combined company after the closing of the concurrent PIPE financing transaction. The investigation focuses on whether Aerpio Pharmaceuticals, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.
AERPIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerpio Pharmaceuticals, Inc. - ARPO
businesswire.com
2021-05-20 21:43:00NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Aerpio Pharmaceuticals, Inc. (“the Company”) (NasdaqGS: ARPO) with Aadi Bioscience, Inc. pursuant to which Aerpio shareholders will own approximately 14.7% of the combined company following the closing of the concurrent PIPE financing. KSF is seeking to determine whether the merger and the process that led t